Not exact matches
Bone marrow transplants are sometimes needed to treat immune diseases that attack these stem
cells, or
in certain types of anaemia,
in which the body can't make enough blood
cells or clotting factors.
These findings may help explain why some people with mutations
in certain ribosomal protein genes develop conditions such as Diamond - Blackfan anemia — a blood disorder
in which the
bone marrow doesn't make enough red blood
cells — but don't have problems
in other body tissues, Ware says.
Although Osteolectin is known to be made by
certain bone marrow and
bone cells, CRI researchers are the first to show Osteolectin promotes the formation of new
bone from skeletal stem
cells in the
bone marrow.
In certain types of aplastic anemia, lymphocytes are responsible for attacking the
bone marrow stem
cells.
Another is to monitor the effects of transplanting telomerase - deficient but ex vivo telomere - extended
bone marrow into late - generation, TMM - disabled mice, so as to be
certain that the niche of such animals (or, by implication, aging humans) will support the homing, engraftment, and initial development and differentiation of such
cells; the necessary research is underway now thanks to a SENS Foundation grant to Dr. Zhenyu Ju of the Institute of Laboratory Animal Sciences and Max - Planck - Partner - Group on Stem
Cell Aging
in the Chinese Academy of Medical Sciences, and research partner of prominent telomere biologist Dr. K. Lenhard Rudolph.
Certain types of mutated stem
cells accumulated
in bone marrow are an accurate predictor of death from cardiovascular disease within a decade.
Changes
in white blood
cell counts can indicate infection or other pathological diseases that affect the
bone marrow, such as
certain forms of cancer.
When
certain cells in your pet's immune system encounter an invader or a vaccine for the first time, some, released from your pet's
bone marrow, produce antibody.
Immunoglobulin levels can also remain above normal
in all forms of autoimmune disease (ref + see ANA) and when tumors have developed
in certain bone marrow cells.